Missing/wrong data?
Log in to edit
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial
scientific article
Author/s
author: Ursula Vehling-Kaiser, Ludwig Fischer von Weikersthal, Clemens Giessen-Jung, Markus M Lerch, Tobias Heintges
Work details
Publication date
August 26, 2016
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.